PUMA BIOTECHNOLOGY, INC. Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Puma Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • Puma Biotechnology, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $22.1M, a 157% increase year-over-year.
  • Puma Biotechnology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $32.4M, a 16.3% increase year-over-year.
  • Puma Biotechnology, Inc. annual Operating Income (Loss) for 2023 was $32.6M, a 37.6% increase from 2022.
  • Puma Biotechnology, Inc. annual Operating Income (Loss) for 2022 was $23.7M, a 1739% increase from 2021.
  • Puma Biotechnology, Inc. annual Operating Income (Loss) for 2021 was $1.29M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $32.6M +$8.92M +37.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $23.7M +$22.4M +1739% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $1.29M +$31.7M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$30.4M +$8.64M +22.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 -$39M +$55.6M +58.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-03
2018 -$94.7M +$198M +67.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$292M -$15.8M -5.71% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 -$277M -$36.3M -15.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$240M -$98M -68.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
2014 -$142M -$87.4M -159% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 -$54.8M +$19.6M +26.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 -$74.5M -$64.3M -633% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 -$10.2M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.